|
⚲
|
| Keyboard |
| Sandoval David I
✚
|
|
|---|---|
| CIK # | 0002012430 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002012430] | |
| 4 | [0002012430] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Milestone Pharmaceuticals Inc | |
| Sandoval David I | |
| Maxcyte Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Maxcyte Inc MXCT
Common Stock
|
2025-03-18 | Sell | 353 | $3.18 | 1,123 |
|
Maxcyte Inc MXCT
Common Stock
|
2025-03-14 | Grant | 23,125 | $0.00 | |
|
Maxcyte Inc MXCT
Employee Stock Option (right to buy) · derivative
|
2025-03-14 | Grant | 92,500 | $0.00 | |
|
Maxcyte Inc MXCT
Common Stock
|
2025-01-13 | Sell | 4,466 | $4.54 | 20,276 |
|
Maxcyte Inc MXCT
Common Stock
|
2024-03-15 | Grant | 3,913 | $0.00 | |
|
Maxcyte Inc MXCT
Employee Stock Option (right to buy) · derivative
|
2024-03-15 | Grant | 15,625 | $0.00 |